Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90

Area of Science:

• Proteomics
• Cancer Biology
• Molecular Oncology

Background:

• Cancers involve numerous molecular changes, complicating the identification of critical proteins in signaling pathways.
• Heat shock protein 90 (Hsp90) is crucial for the stability and function of many oncogenic proteins.

Purpose of the Study:

• To develop and validate a proteomic strategy using PU-H71 to identify Hsp90-dependent oncoproteins and dysregulated networks in cancer.
• To assess the potential of this method for discovering novel therapeutic targets and predicting treatment response.

Main Methods:

• Utilized PU-H71, a selective Hsp90 inhibitor, for affinity capture of Hsp90 complexes and associated client proteins.
• Integrated proteomic data with bioinformatic pathway analysis to identify key signaling alterations.
• Analyzed primary patient specimens and correlated Hsp90 species abundance with drug sensitivity.

Main Results:

• PU-H71 affinity capture successfully identified known and novel Hsp90 client proteins and dysregulated networks in chronic myeloid leukemia.
• The identified protein interactome provided global insights into tumor-specific molecular biology.
• Abundance of PU-H71-enriched Hsp90 species, independent of Hsp90 expression, predicted sensitivity to Hsp90 inhibition.

Conclusions:

• PU-H71 affinity capture is a powerful tool for dissecting cancer signaling networks and identifying therapeutic targets.
• This proteomic approach offers a global view of tumor biology and has potential for personalized medicine.
• The method can uncover previously unknown oncoproteins and mechanisms, paving the way for novel targeted cancer therapies.